Malaria Cases in the U.S. Reach 40-Year High: Information and Guidance for Clinicians

Presenter(s)

Overview

The number of malaria cases reported in the United States in 2011 was the largest since 1971, representing a 14% increase from 2010 and a 48% increase from 2008. The majority of malaria infections occurred among persons who traveled to regions with ongoing malaria transmission. Imported malaria can reintroduce malaria into regions where the disease is not endemic and environmental conditions are present that support the lifecycle of the parasite. During this COCA call, a CDC subject matter expert will describe malaria prevention strategies aimed at reducing the risk of malaria in travelers, discuss the diagnosis of malaria in patients with suspect malaria, and explain the treatment options for confirmed malaria cases.

Objectives

At the conclusion of the session, the participant will be able to accomplish the following:

• Explain the principal malaria prevention strategies in travelers.
• Describe how to diagnose malaria in the U.S.
• Discuss the treatment options for uncomplicated and severe malaria.

Call Materials

• Slides: View Now
• Webcast: Watch Now
• Audio: Listen Now
• Transcript:Read Now

Additional Resources

• Malaria Surveillance — United States, 2011. Morbidity and Mortality Weekly Report (MMWR). Surveillance Summaries. November 1, 2013. 62(ss05); 1-17
• CDC Malaria Diagnosis and Treatment in the United States
• CDC How to Report a Case of Malaria
• COCA Commentary Podcast

Call Format

• Live audio conference call on 01/28/14, 2:00 - 3:00 PM
• Audio-on-demand training after 3:00 PM on 01/28/14
• Materials: PowerPoint slide set

Additional Call Information

Accreditation Statements

CME:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME^®) to provide continuing medical education for physicians.

The Centers for Disease Control and Prevention designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CNE:The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation.

This activity provides 1.0 contact hour.

IACET CEU:The CDC has been approved as an Authorized Provider by the International Association for Continuing Education and Training (IACET), 1760 Old Meadow Road, Suite 500, McLean, VA 22102. The CDC is authorized by IACET to offer 0.1 ANSI/IACET CEU's for this program.

CECH:Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to total 1.0 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number GA0082.

CPE:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is a designated event for pharmacists to receive 0.1 CEUs in pharmacy education. The Universal Activity Number is 0387-0000-14-075-L04-P and enduring 0387-0000-14-075-H04-P.

This program is knowledge based.

AAVSB/RACE:This program was reviewed and approved by the AAVSB RACE program for 1.0 hours of continuing education in the jurisdictions which recognize AAVSB RACE approval. Please contact the AAVSB RACE Program at race@aavsb.org if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.

DISCLOSURE:In compliance with continuing education requirements, CDC, our planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.

The presentation will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC does not accept commercial support.